论文部分内容阅读
学习目标:在第一季度外科(泌尿外科)继续教育课程中应当掌握: 1.肾移植的历史及现状; 2.肾移植的免疫现状; 3.先天性免疫的临床进展。 上一节我们讲到免疫抑制剂的近期发展,本节我们将继续就该问题进行深入探讨。3免疫抑制剂的进展 3.1早期免疫抑制剂 3.2免疫抑制剂的近期发展 (1)干扰淋巴细胞激活的免疫抑制 作为标志肾移植发展史的里程碑,免疫抑制的研究已经走出了以往的陈旧模式,即先在大量体外试验中找到一种
Learning Objectives: In the first quarter of surgery (Urology) continuing education courses should be mastered: 1. History and current status of kidney transplantation; 2. Immune status of renal transplantation; 3. Clinical progress of innate immunity. We talked about the recent development of immunosuppressants in the previous section, we will continue to explore this issue in depth in this section. 3. Progress of Immunosuppressive Agents 3.1 Early Immunosuppressive Agents 3.2 Recent Developments of Immunosuppressive Agents (1) Immunosuppression that Interferes with Lymphocyte Activation As a milestone in the history of the development of renal transplantation, immunosuppression has gone beyond the old model of aging First in a large number of in vitro tests to find one